Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk M Nettelbeck

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Cancer Immunology, Immunotherapy : CII|January 31, 2018
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approachAngela M Krackhardt, Brigitte Anliker, Martin Hildebrandt, et al.
Melanoma Research|March 14, 2008
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cellsMichael Schwenkert, Katrin Birkholz, Michael Schwemmlein, et al.
Plos One|April 25, 2014
Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffoldsMichael Behr, Johanna K Kaufmann, Patrick Ketzer, et al.
Molecular Therapy Oncolytics|March 28, 2017
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell TherapyRiikka Havunen, Mikko Siurala, Suvi Sorsa, et al.
Molecular and Cellular Biology|January 24, 2013
Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cellsMarcello F Stein, Stefan Lang, Thomas H Winkler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2014
CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapyChristine E Engeland, Christian Grossardt, Rūta Veinalde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancerDaniel T Rein, Martina Breidenbach, Tyler O Kirby, et al.
Molecular Oncology|December 19, 2018
German Cancer Consortium (DKTK) - A national consortium for translational cancer researchStefan Joos, Dirk M Nettelbeck, Anette Reil-Held, et al.
The Journal of Gene Medicine|September 16, 2004
Evaluation of tissue-specific promoters in carcinomas of the cervix uteriDaniel T Rein, Martina Breidenbach, Dirk M Nettelbeck, et al.
Cancer Cell|October 19, 2013
DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signalingMarc Steder, Vijay Alla, Claudia Meier, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|January 31, 2018
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approachAngela M Krackhardt, Brigitte Anliker, Martin Hildebrandt, et al.
Melanoma Research|March 14, 2008
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cellsMichael Schwenkert, Katrin Birkholz, Michael Schwemmlein, et al.
Plos One|April 25, 2014
Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffoldsMichael Behr, Johanna K Kaufmann, Patrick Ketzer, et al.
Molecular Therapy Oncolytics|March 28, 2017
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell TherapyRiikka Havunen, Mikko Siurala, Suvi Sorsa, et al.
Molecular and Cellular Biology|January 24, 2013
Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cellsMarcello F Stein, Stefan Lang, Thomas H Winkler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2014
CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapyChristine E Engeland, Christian Grossardt, Rūta Veinalde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancerDaniel T Rein, Martina Breidenbach, Tyler O Kirby, et al.
Molecular Oncology|December 19, 2018
German Cancer Consortium (DKTK) - A national consortium for translational cancer researchStefan Joos, Dirk M Nettelbeck, Anette Reil-Held, et al.
The Journal of Gene Medicine|September 16, 2004
Evaluation of tissue-specific promoters in carcinomas of the cervix uteriDaniel T Rein, Martina Breidenbach, Dirk M Nettelbeck, et al.
Cancer Cell|October 19, 2013
DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signalingMarc Steder, Vijay Alla, Claudia Meier, et al.
Pageof 7